Duvortuxizumab Uses, Dosage, Side Effects and more
Duvortuxizumab is under investigation in clinical trial NCT02743546 (Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma).
Trade Name | Duvortuxizumab |
Generic | Duvortuxizumab |
Duvortuxizumab Other Names | Duvortuxizumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |